Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

633 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs.
Nakanishi C, Toi M. Nakanishi C, et al. Nat Rev Cancer. 2005 Apr;5(4):297-309. doi: 10.1038/nrc1588. Nat Rev Cancer. 2005. PMID: 15803156 Review.
Quantitative analysis of vascular endothelial growth factor in primary breast cancer.
Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T, Tominaga T. Toi M, et al. Cancer. 1996 Mar 15;77(6):1101-6. doi: 10.1002/(sici)1097-0142(19960315)77:6<1101::aid-cncr15>3.0.co;2-5. Cancer. 1996. PMID: 8635130
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.
Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A, Toi M. Taniguchi T, et al. Br J Cancer. 1997;75(5):673-7. doi: 10.1038/bjc.1997.120. Br J Cancer. 1997. PMID: 9043023 Free PMC article.
Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma.
Suzuki A, Toi M, Yamamoto Y, Saji S, Muta M, Tominaga T. Suzuki A, et al. Jpn J Cancer Res. 1998 Feb;89(2):221-7. doi: 10.1111/j.1349-7006.1998.tb00552.x. Jpn J Cancer Res. 1998. PMID: 9548451 Free PMC article.
Serum concentrations of hepatocyte growth factor in breast cancer patients.
Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y, Tominaga T. Taniguchi T, et al. Clin Cancer Res. 1995 Sep;1(9):1031-4. Clin Cancer Res. 1995. PMID: 9816076
[Antiangiogenic therapy].
Toi M. Toi M. Gan To Kagaku Ryoho. 1998 Nov;25(13):2003-9. Gan To Kagaku Ryoho. 1998. PMID: 9838900 Review. Japanese.
Metalloproteinases and tissue inhibitors of metalloproteinases.
Toi M, Ishigaki S, Tominaga T. Toi M, et al. Breast Cancer Res Treat. 1998;52(1-3):113-24. doi: 10.1023/a:1006167202856. Breast Cancer Res Treat. 1998. PMID: 10066076 Review.
Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.
Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M, Seiki M. Ishigaki S, et al. Jpn J Cancer Res. 1999 May;90(5):516-22. doi: 10.1111/j.1349-7006.1999.tb00778.x. Jpn J Cancer Res. 1999. PMID: 10391091 Free PMC article. Clinical Trial.
633 results
Jump to page
Feedback